BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2003
View Archived Issues
Bayer claims new inhibitors of SPEK kinase and their use in cancer therapy
Read More
Novel somatostatin sst1 antagonists, their preparation and use reported by Novartis
Read More
New series of GSK-3beta inhibitors under study at Janssen
Read More
Merz describes new agents with multiple mechanism of action for neurological disorders
Read More
Novartis designs new PDE4 inhibitors with utility in asthma
Read More
Schering AG researchers design lipoxin A4 analogues for allergy, inflammation, etc.
Read More
Mitotic kinesin KSP inhibitors identified at Merck
Read More
FDA sets Hemopure review date
Read More
FeRx opens phase II/III trial of MTC-doxorubicin
Read More
Biphasix interferon alfa cream to enter phase II in 2004
Read More
Lundbeck sells stake in Cephalon
Read More
Final EVIDENCE data support Rebif over Avonex in MS
Read More
Topiglan enters new phase II study for erectile dysfunction
Read More
Statin-derived LFA-1 inhibitor proves effective as an immunosuppressant in mice
Read More
Novartis presents efficacy and safety data for fully human anti-CD154 MAb
Read More
Memantine plus donepezil improves cognition in Alzheimer's disease
Read More
Escitalopram reported safe and effective in anxiety and depressive disorders
Read More
Influence of sildenafil on duodenal function and cirrhotic portal hemodynamics
Read More
Ciclesonide safe and equieffective to budesonide in the management of asthma
Read More
Tiagabine clinical trial results presented in San Francisco
Read More
Potential agent for prostate cancer available for licensing from BTG
Read More
